The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Share News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Coastal Energy, Oxford Instruments, Byotrol...

Tue, 16th Nov 2010 12:34

Coastal Energy Company is bucking the market trend, up sharply on news of a find at the Songkhla A-09 well in the Gulf of Thailand and the resumption of production at pre-shutdown levels of 10,000 barrels of oil per day (bopd) following a weather delay.The latest discovery is similar to the A-08 well which initially flow tested 1,100 bopd and has been the best performing well at Songkhla so far. High-tech instruments maker Oxford Instruments has had an "excellent" half-year and boasts an order book at record levels after a 5.5% hike in order intake to £141.3m. Revenue jumped 22% to £113.2m.Favourable currency moves formed a "significant" part of the increase in adjusted pre-tax profit to £10.6m from £2.8m in 2009. Bu the company says most of the FX benefit for the year has probably been realised in the first half."Current levels of customer interest indicate that demand will continue to be strong for the remainder of the current financial year," chairman Nigel Keen said. "We are actively pursuing acquisition targets that have the potential to enhance value and our technical capabilities."Germ killing technology company Byotrol has suffered a big decline in first half sales, down to £922,000 from £2m the year before when the swine flu scare created massive demand for hand hygiene products.Excluding licence receipts and the swine flu boost, sales rose £30,000 to £580k, but the reported loss widened to £1.26m from £590k despite a 25% reduction in overhead costs.Management Consulting Group has had a mixed period since the half-year results on 2 August. It's enjoyed a strong recovery at Alexander Proudfoot and Kurt Salmon Associates, although the latter's US recovery is slow.Ineum, soon to merge with Kurt Salmon, had a patchy first half in France and its second half performance has all been affected by challenging conditions."Overall the board believes that the outlook is improving, albeit at a slightly slower pace than desired," boss Nick Stagg said. "MCG continues to believe that the business is well positioned to benefit from the recovery as it materialises."Harvard International, a distributor of consumer electronic goods in the UK and Australia, was hit by weak demand during the six months ended 30 September, dropping sales to £30.1m from £42.5m in 2009.That caused a loss before tax of £0.5m at the company formerly known as Alba compared with a £0.3m profit the year before. Full-year results are expected to be in line with forecasts.
More News
21 Dec 2009 12:00

London midday: Oil fired Footsie

Oil is fuelling the Footsie's rise today, with support from back-in-favour banks. Cairn Energy has secured a drill ship to get an early start on its exploration activities in Greenland. The oil company said drilling in Greenland will start a year ahead of schedule after it came to a deal with Hess

Read more
21 Dec 2009 08:59

US patent boosts Byotrol

Germ killing technology company Byotrol's share price received a boost after it said that it had its US patent application accepted. Byotrol, which applied for the patent in 2002, said the patent runs until 2022. Meanwhile, a Fortune 150 multinational company has paid Byotrol and its joint ventur

Read more
20 Nov 2009 17:28

Jorge Cosmen raises National Express stake

Shares in National Express raced ahead after deputy chairman Jorge Cosmen increased his family's influence over the company, spending more than £1.7m on shares in the train and bus operator. He bought just over 500,000 shares at 341p a time and now has about 29m, which is just shy of 20% of the com

Read more
17 Nov 2009 14:37

Byotrol's bumper interim revenues

Anti-microbial technology developer Byotrol reported strong revenue growth in the six months to September 2009 but this rate of growth will be difficult to maintain. Revenues jumped from £388,000 to £2m - more than double the level for the previous 12 months. Publicity about swine flu and other in

Read more
17 Sep 2009 08:39

Small caps round-up: Byotrol, ReNeuron, Accuma...

Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30 to be ahead of expectations. Shares in Meridian Petroleum gushed higher after the oil and gas firm announced an increase in prospective resources in

Read more
16 Jun 2009 14:18

Kugler appointed chairman at Byotrol

Germ killing product developer Byotrol saw losses widen and sales slide slightly last year but said the current outlook is promising, as test results demonstrate the effectiveness of its hygiene technology. Revenue in the year to 31 March 2009 eased to £0.93m from £0.95m the year before, while loss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.